頁籤選單縮合
題名 | The Impact of Pathological Complete Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of Esophagus |
---|---|
作 者 | Lin, Jing-wei; Hsu, Chung-ping; Yeh, Hui-ling; Chuang, Cheng-yen; Lin, Chih-hung; | 書刊名 | Journal of the Chinese Medical Association |
卷期 | 81:1 2018.01[民107.01] |
頁次 | 頁18-24 |
分類號 | 416.216 |
關鍵詞 | Esophageal cancer; Neoadjuvant chemoradiotherapy; Pathological complete response; Squamous cell carcinoma; |
語文 | 英文(English) |
英文摘要 | Background: The impact of pathological complete response after neoadjuvant chemoradiotherapy on survival of patients with squamous cell carcinoma of esophagus is still controversial. We retrospectively investigated the survival outcome in this group of patients. Methods: Ninety-eight patients with locally advanced squamous cell carcinoma of esophagus, who received neoadjuvant chemoradiotherapy were included in this retrospective analysis. Treatment protocols were radiotherapy with standard dose 50.4 Gy/28 fr, and chemotherapy with cisplatin 20 mg/m2 and 5-FU 800 mg/m2 for 4 days given on week 1 and 5. After neoadjuvant chemoradiotherapy is completed, patients who were eligible for surgery received surgery within 4e6 weeks. Patients who were not suitable for surgery were shifted to definite chemoradiotherapy. The primary end points were overall survival and progression-free survival. Results: Sixty-eight patients out of the ninety-eight patients received surgery after neoadjuvant chemoradiotherapy. There were 32 patients who achieved pathological complete response with a pCR rate of 47%. Thirty patients were shifted to definite concurrent chemoradiotherapy. The 2- year overall survival rate was 81.3% in the patients whose tumors showed a pCR and 58.3% in the patients with tumors that had a pathological partial response (p ¼ 0.025). The 2-year overall survival in patients who received neoadjuvant chemoradiotherapy followed by surgery and definite chemoradiotherapy were 69.1% and 40.0%, respectively. There are 13 patients experienced grade 3e4 adverse event. Conclusion: Pathological complete response after neoadjuvant chemoradiotherapy is associated with a significant survival benefit in patients with locally advanced squamous cell carcinoma of esophagus. The toxicities related to neoadjuvant chemoradiotherapy were tolerable. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。